News

Stallion India Fluorochemicals Limited submitted a certificate to the National Stock Exchange of India Limited and BSE Limited under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, confirming the regulation is not applicable as all shares are held in demat form and no rematerialisation requests were received during the period, according to a filing on October 6, 2026.

Stallion India Fluorochemicals Limited will close its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of the company’s unaudited financial results for the quarter and half year ended September 30, 2026, in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015.

Stallion India Fluorochemicals will hold a meeting of the Board of Directors of the Company on 12 August 2026.

Net profit of Stallion India Fluorochemicals declined 17.63% to Rs 10.93 crore in the quarter ended March 2026 as against Rs 13.27 crore during the previous quarter ended March 2025. Sales declined 27.43% to Rs 109.99 crore in the quarter ended March 2026 as against Rs 151.57 crore during the previous quarter ended March 2025.For the full year,net profit rose 35.60% to Rs 43.84 crore in the year ended March 2026 as against Rs 32.33 crore during the previous year ended March 2025. Sales rose 14.10% to Rs 430.68 crore in the year ended March 2026 as against Rs 377.45 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales109.99151.57 -27 430.68377.45 14 OPM %14.8612.35 -13.4412.65 - PBDT17.2618.56 -7 60.4643.60 39 PBT16.6618.26 -9 58.9842.43 39 NP10.9313.27 -18 43.8432.33 36 Powered by Capital Market - Live News

Stallion India Fluorochemicals will hold a meeting of the Board of Directors of the Company on 13 May 2026.